Med Business World

Your source for healthcare business

Psychology Scope

Acharya Prashant Engages with IIT Students on Mental Health and Spiritual Well-being

Acharya Prashant, founder of PrashantAdvait Foundation and former civil service officer, interacted with IIT students on mental health. More than 1000 people from across the country participated in the session. He said that there is a deep connection between the…

Gedeon Richter: Cariprazine Proves Effective in Treating Dual Diagnosis

New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of the European Psychiatric Association held April 6-9 in Budapest, Hungary. According to scientific posters of the event, cariprazine could be an appropriate treatment not only for…

A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born

The9 Limited (Nasdaq: NCTY) (“The9”), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) (“WM Therapeutics”) has achieved revolutionary breakthroughs in the proprietarily developed research and development of antidepressant drug precision treatment. WM Therapeutics’ GenAI multi-dimensional omics…

Mansathali Intervenes to Rescue Child from Social Media Addiction

Today, the whole world is dominated by digital technology; it doesn’t matter what your age or gender is, you are tech addicted. Concerns about the impact of social media addiction on children’s well-being have become more pressing than ever. However,…

Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder. NBI-1070770 is a novel,…

Join Els for Autism® in Celebrating World Autism Month: Creating Opportunities for Inclusion and Acceptance of Individuals with Autism Spectrum Disorder

As we prepare to celebrate World Autism Month this April, Els for Autism invites individuals and families to join us in our mission of creating a world of limitless possibilities for individuals with autism spectrum disorder (ASD) and their families. Through our…

Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders

Gabather AB (Nasdaq First North Growth Market: GABA) today reports that two new US provisional patent applications based on novel findings from the EEG/fMRI target engagement study with GT-002, a selective positive allosteric GABAA-receptor modulator. The inventions relate to the…

Apex Labs Files for US Patent Protecting Psychedelic Drug Delivery System

Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO). The patent…

Gateways Hospital and Mental Health Center Opens New Sensory Room, Providing Vulnerable Clients with Innovative, Client-Centered Care

Gateways Hospital and Mental Health Center unveiled its groundbreaking Sensory Room, a pioneering addition to acute patient care in Los Angeles, generously funded by a $45,000 grant from the Robert Ellis Simon Foundation. This innovative space signifies Gateways’ commitment to implementing client-centered approaches,…

New Paper Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, Demonstrates Correlation Between the Presence of Misfolded α-Synuclein and Clinical Presentations of Alzheimer’s Disease

Amprion is pleased to be affiliated with a new scientific paper published in Alzheimer’s & Dementia, entitled “Investigating alpha-synuclein co-pathology in Alzheimer’s disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay,” led by University of Perugia Professor, Dr. Lucilla Parnetti and Amprion…